CY1109710T1 - Επιτοπα βοηθητικων τ λεμφοκυτταρων - Google Patents

Επιτοπα βοηθητικων τ λεμφοκυτταρων

Info

Publication number
CY1109710T1
CY1109710T1 CY20091101243T CY091101243T CY1109710T1 CY 1109710 T1 CY1109710 T1 CY 1109710T1 CY 20091101243 T CY20091101243 T CY 20091101243T CY 091101243 T CY091101243 T CY 091101243T CY 1109710 T1 CY1109710 T1 CY 1109710T1
Authority
CY
Cyprus
Prior art keywords
epitopes
lymphocyte
auxiliary site
taaqitaglalhqsnln
sgrrqrrfagvvlagva
Prior art date
Application number
CY20091101243T
Other languages
English (en)
Inventor
David Charles Jackson
Souravi Ghosh
John Walker
Original Assignee
The University Of Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP8533A external-priority patent/AUPP853399A0/en
Priority claimed from AUPQ2013A external-priority patent/AUPQ201399A0/en
Application filed by The University Of Melbourne filed Critical The University Of Melbourne
Publication of CY1109710T1 publication Critical patent/CY1109710T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Detergent Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Luminescent Compositions (AREA)

Abstract

Η παρούσα εφεύρεση παρέχει επίτοπα και συνθέσεις βοηθητικών Τ λεμφοκυττάρων για χρήση στην επαγωγή μίας ανοσολογικής απόκρισης που περιλαμβάνει τουλάχιστον ένα από αυτά τα επίτοπα. Τα επίτοπα περιέχονται στην ακολουθία πεπτιδίων που επιλέγεται από την ομάδα που αποτελείται από SSKTQTHTQQDRPPQPS. QPSTELEETRTSRARHS. RHSTTSAQRSTHYDPRT. PRTSDRPVSYTMNRTRS. TRSRKQTSHRLKNIPVH. SHQYLVIKLIPNASLIE. IGTDNVHYIKIMTRPSHQ. YKIMTRPSHQYLVIKLI- KLIPNASLIENCTKAEL. AELGEYEKLLNSVLEPI. EPINQALTLMTKNVKPL. FAGVVLAGVALGVATAA. TAAQITAGLALHQSNLN. GIALHQSNLNAQAIQSL. NLNAQAIQSLRTSLEQS. QSLRTSLEQSNKAIEEI. EQSNKAIEEIREATQET. TELLSIFGPSLRDPISA. PRYIATNGYLISNFDES. CIRGDTSSCARTLVSGT. DESSCVFVSESAICSQN. TSTIINQSPDKLLTFIA, SPDKLLTFIASDTCPLV και SGRRQRRFAGVVLAGVA.
CY20091101243T 1999-02-05 2009-11-26 Επιτοπα βοηθητικων τ λεμφοκυτταρων CY1109710T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP8533A AUPP853399A0 (en) 1999-02-05 1999-02-05 T helper cell epitopes
AUPQ2013A AUPQ201399A0 (en) 1999-08-04 1999-08-04 T-helper cell epitopes
EP00906047A EP1147212B1 (en) 1999-02-05 2000-02-07 T helper cell epitopes

Publications (1)

Publication Number Publication Date
CY1109710T1 true CY1109710T1 (el) 2014-08-13

Family

ID=25645983

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091101243T CY1109710T1 (el) 1999-02-05 2009-11-26 Επιτοπα βοηθητικων τ λεμφοκυτταρων

Country Status (15)

Country Link
US (5) US6685947B1 (el)
EP (2) EP2103691A1 (el)
JP (2) JP4699612B2 (el)
KR (2) KR100905264B1 (el)
AT (1) ATE440960T1 (el)
AU (1) AU765164B2 (el)
CA (1) CA2361658C (el)
CY (1) CY1109710T1 (el)
DE (1) DE60042816D1 (el)
DK (1) DK1147212T3 (el)
ES (1) ES2332701T3 (el)
NZ (1) NZ513482A (el)
PT (1) PT1147212E (el)
WO (1) WO2000046390A1 (el)
ZA (1) ZA200106413B (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4699612B2 (ja) * 1999-02-05 2011-06-15 ザ ユニバーシティ オブ メルボーン Ｔヘルパー細胞エピトープ
US20050106137A1 (en) * 2000-05-05 2005-05-19 Stephen Grimes Chimeric peptide immunogens
AU2002249895A1 (en) * 2001-01-05 2002-07-16 Joslin Diabetes Center, Inc. Autoantigen composition
EP2314630A1 (en) 2002-08-12 2011-04-27 The Council Of The Queensland Institute Of Medical Research Method of producing immunogenic lipopeptides comprising T-helper and Cytotoxic T Lymphocyte (CTL) epitopes
KR101240547B1 (ko) 2002-08-12 2013-03-08 더 카운실 오브 더 퀸스랜드 인스티튜트 오브 메디칼 리서어치 Ｔ-헬퍼 및 ｂ-세포 에피토프를 포함하는 신규한 면역원성리포펩타이드
US7178491B2 (en) * 2003-06-05 2007-02-20 Caterpillar Inc Control system and method for engine valve actuator
CA2571168A1 (en) * 2004-06-17 2006-01-26 Mannkind Corporation Mhc i-binding ssx-241-49 variants
CN101084239A (zh) * 2004-09-10 2007-12-05 昆士兰医学研究所理事会（Qimr） 截短的lhrh制剂
AU2005282231B2 (en) * 2004-09-10 2011-03-10 The Council Of The Queensland Institute Of Medical Research (Qimr) Truncated LHRH formulations
AU2006236294A1 (en) 2005-04-19 2006-10-26 Eli Lilly And Company Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease
KR20080007648A (ko) * 2005-06-01 2008-01-22 화이자 프로덕츠 인코포레이티드 요실금 치료용 백신 조성물 및 방법
AU2006259307B2 (en) 2005-06-17 2012-12-20 Mannkind Corporation Epitope analogues
ES2413079T3 (es) 2005-06-17 2013-07-15 Mannkind Corporation Métodos y composiciones para desencadenar respuestas inmunitarias multivalentes contra epítopos dominantes y subdominantes expresados en células cancerosas y estroma tumoral
WO2007127787A2 (en) * 2006-04-25 2007-11-08 Joslin Diabetes Center, Inc. Insulin autoantigen-specific regulatory cd4+ t cells
CO2021017322A1 (es) * 2021-12-16 2023-06-20 Univ Cooperativa De Colombia Péptidos inmunogénicos contra el virus distemper canino (cdv)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047238A (en) 1983-06-15 1991-09-10 American Home Products Corporation Adjuvants for vaccines
US5756102A (en) 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
US6309647B1 (en) * 1999-07-15 2001-10-30 Aventis Pasteur Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
JP2001513120A (ja) 1997-02-11 2001-08-28 ザ カウンシル オブ ザ クイーンズランド インスティチュート オブ メディカル リサーチ ペプチドを含むポリマー
JP4699612B2 (ja) * 1999-02-05 2011-06-15 ザ ユニバーシティ オブ メルボーン Ｔヘルパー細胞エピトープ

Also Published As

Publication number Publication date
DE60042816D1 (de) 2009-10-08
KR100955668B1 (ko) 2010-05-06
EP2103691A1 (en) 2009-09-23
JP2002536384A (ja) 2002-10-29
CA2361658C (en) 2013-04-09
WO2000046390A1 (en) 2000-08-10
AU765164B2 (en) 2003-09-11
DK1147212T3 (da) 2010-01-04
EP1147212B1 (en) 2009-08-26
CA2361658A1 (en) 2000-08-10
AU2783600A (en) 2000-08-25
US20070248615A1 (en) 2007-10-25
KR100905264B1 (ko) 2009-06-29
US20050037014A1 (en) 2005-02-17
US20050186220A1 (en) 2005-08-25
US7037507B2 (en) 2006-05-02
US20060199177A1 (en) 2006-09-07
JP4699612B2 (ja) 2011-06-15
ATE440960T1 (de) 2009-09-15
EP1147212A4 (en) 2004-03-31
KR20010101796A (ko) 2001-11-14
JP2011121965A (ja) 2011-06-23
ES2332701T3 (es) 2010-02-11
KR20090015892A (ko) 2009-02-12
NZ513482A (en) 2003-08-29
PT1147212E (pt) 2009-12-03
US7572454B2 (en) 2009-08-11
EP1147212A1 (en) 2001-10-24
US6685947B1 (en) 2004-02-03
ZA200106413B (en) 2002-08-05
US7097844B2 (en) 2006-08-29
US7241448B2 (en) 2007-07-10

Similar Documents

Publication Publication Date Title
CY1109710T1 (el) Επιτοπα βοηθητικων τ λεμφοκυτταρων
CY1113379T1 (el) Πεπτιδια κdr και εμβολια που τα περιλαμβανουν
CY1113421T1 (el) Πυρηνικα οξεα και πολυπεπτιδια υποδοχεα
CY1105364T1 (el) Μεθοδοι και συνθεσεις διαμορφωσης ανοσοποιησης
CY1108083T1 (el) Αντιγονα και συνθεσεις του neisseria meningitidis
CY1108299T1 (el) Πεπτιδια του ιου ανθρωπινης ανοσοανεπαρκειας (hiv), αντιγονα και συνθεσεις εμβολιου
CY1119291T1 (el) Πολυσθενη αντισωματα και χρησεις για αυτα
CY1117387T1 (el) ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ Ν-11 ΔΙΑΣΠΑΣΜΕΝΟΥ β-ΑΜΥΛΟΕΙΔΟΥΣ, ΣΥΝΘΕΣΕΙΣ, ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ
TR200102029T2 (tr) 1-Heterosiklil ikameli diarilaminler.
ATE196314T1 (de) Verfahren und zusammensetzungen zur verhinderung von entzündungen und angiogenese enthaltend säugetieren cd97 alpha untereinheit
TR199900848T2 (xx) Oksadiazoller, elde edilmeleri ve ila� olarak kullan�mlar�.
TR199900267T2 (xx) GnRH-L�kotoksin kimeralar�.
PE20030316A1 (es) Sistema de suministro de dos o mas agentes terapeuticamente activos
ATE463505T1 (de) Toll-ähnlichen-rezeptor-5-liganden und verwendungsverfahren
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
CY1107628T1 (el) Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
CY1108387T1 (el) Ανταγωνιστες ανασυνδυασμενης il-18 χρησιμοι στη θεραπεια παθησεων που εμφανιζονται με διαμεσολαβηση της il-18
NO20044039L (no) Konjugatorer av terapeutiske eller cytotoksiske midler og biologisk aktive peptider.
CY1109439T1 (el) Αναλογα γλυκοπρωτεϊνικων ορμονων δισουλφιδικης σταυρωτης συνδεσης, η παρασκευη και η χρηση τους
SE9704546D0 (sv) Novel compounds
CY1109699T1 (el) Νουκλεινικα οξεα που κωδικοποιουν πολυπεπτιδια πολυεπιτοπων
CY1105452T1 (el) Παραγωγα της κυκλοσπορινης και μεθοδος παρασκευης των εν λογω παραγωγων
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
CY1105008T1 (el) Αντιμικροβιακη ενεργοτητα του πρωτου κατιονικου συγκροτηματος της ανθρωπινης λακτοφερρινης
CY1109812T1 (el) Αντιγονικα πολυπεπτιδια neisseira meningitidis (μηνιγγιτιδοκοκκου), αντιστοιχα πολυνουκλεοτιδια και προστατευτικα αντισωματα